Shares of Alere plunged Friday morning after the company disclosed in a filing that one of its units has seen its Medicare enrollment revoked. The Centers for Medicare & Medicaid Services alleged that ...
Finally the much contentious merger of Abbott Laboratories ABT with Alere is nearing its close. As expected, the financial terms of the deal have been amended. Per the amended terms of the agreement, ...
April 14 (Reuters) - Abbott Laboratories agreed to buy diagnostic-testing company Alere Inc for $4.4 billion, ending a prolonged legal battle over Abbott's plan to buy the company, the Financial Times ...
Shares of Alere (NYSE: ALR), a provider of diagnostic tests to the medical community for disease detection, plunged as much as 16% during Friday's trading session after releasing disappointing ...
Alere's stock fell 13% on Wednesday after the CEO of suitor Abbott Laboratories' meh comment on its proposed acquisition of Alere. Here's what Miles White said in response to JP Morgan analyst Michael ...
Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Diversified healthcare company Abbott Laboratories on Friday agreed to buy Alere Inc at a lower price than it had ...
, an Alere subsidiary specializing in analytics and clinical decision support (CDS) technology, today announced the launch of its Clinical Surveillance product for hospitals, which is an automated ...
What: Shares of Alere (NYSE: ALR), a pioneer of quick, point-of-care diagnostics, sank by 22.9% in April, according to data from S&P Global Market Intelligence. All it took was an off-the-cuff comment ...
Alere agreed to pay $33.2 million to resolve False Claims Act allegations that it knowingly sold defective point-of-care diagnostic testing devices. Here are five insights. 1. The U.S. Justice ...
Federal criminal investigators have opened a new front in a probe of diagnostic testing company Alere, according to a new report that comes as the firm continues trying to sell itself to in a ...
Prosecutors claim that Alere continued to sell its Triage cardiac and drug test kids even as providers made it known that the device was faulty. The FDA recalled Triage in 2012. Medical device maker ...
North suburban-based Abbott Laboratories is making up with Alere after nearly a year of fighting, agreeing to buy the Massachusetts-based company for a lower price and ending its legal battles over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results